156 related articles for article (PubMed ID: 20127014)
21. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.
Cortezzi SS; Provazzi PJ; Sobrinho JS; Mann-Prado JC; Reis PM; de Freitas SE; Filho JF; Fukuyama EE; Cordeiro JA; Cury PM; Maniglia JV; Villa LL; Tajara EH; Rahal P
Cancer Genet Cytogenet; 2004 Apr; 150(1):44-9. PubMed ID: 15041222
[TBL] [Abstract][Full Text] [Related]
22. [Expression of p53 gene in oral squamous cell carcinoma and its relations with clinical and pathological parameters and prognosis of patients].
Mao C; Lu Y; Lai Q; Xia Y; Yang C
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Aug; 18(4):257-62. PubMed ID: 9388973
[TBL] [Abstract][Full Text] [Related]
23. Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis.
Matakidou A; El Galta R; Rudd MF; Webb EL; Bridle H; Eisen T; Houlston RS
Br J Cancer; 2007 Jun; 96(12):1904-7. PubMed ID: 17519899
[TBL] [Abstract][Full Text] [Related]
24. TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma.
Perrone F; Bossi P; Cortelazzi B; Locati L; Quattrone P; Pierotti MA; Pilotti S; Licitra L
J Clin Oncol; 2010 Feb; 28(5):761-6. PubMed ID: 20048189
[TBL] [Abstract][Full Text] [Related]
25. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients.
Shen YY; Lu YC; Shen DP; Liu YJ; Su XY; Zhu GS; Yin XL; Ni XZ
World J Gastroenterol; 2013 Jul; 19(28):4568-75. PubMed ID: 23901234
[TBL] [Abstract][Full Text] [Related]
27. TP53 mutation, allelism and survival in non-small cell lung cancer.
Nelson HH; Wilkojmen M; Marsit CJ; Kelsey KT
Carcinogenesis; 2005 Oct; 26(10):1770-3. PubMed ID: 15905205
[TBL] [Abstract][Full Text] [Related]
28. TP53 codon 72 polymorphism in oral squamous cell carcinoma.
Drummond SN; De Marco L; Pordeus Ide A; Barbosa AA; Gomez RS
Anticancer Res; 2002; 22(6A):3379-81. PubMed ID: 12530090
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of truncating TP53 mutations in head and neck squamous cell carcinoma.
Lindenbergh-van der Plas M; Brakenhoff RH; Kuik DJ; Buijze M; Bloemena E; Snijders PJ; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2011 Jun; 17(11):3733-41. PubMed ID: 21467160
[TBL] [Abstract][Full Text] [Related]
30. Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer.
Hassan NM; Tada M; Hamada J; Kashiwazaki H; Kameyama T; Akhter R; Yamazaki Y; Yano M; Inoue N; Moriuchi T
Cancer Lett; 2008 Oct; 270(1):108-19. PubMed ID: 18555592
[TBL] [Abstract][Full Text] [Related]
31. DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients.
Gal TJ; Huang WY; Chen C; Hayes RB; Schwartz SM
Laryngoscope; 2005 Dec; 115(12):2221-31. PubMed ID: 16369171
[TBL] [Abstract][Full Text] [Related]
32. Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.
Azad AK; Bairati I; Samson E; Cheng D; Mirshams M; Qiu X; Savas S; Waldron J; Wang C; Goldstein D; Xu W; Meyer F; Liu G
Clin Cancer Res; 2012 Jan; 18(1):196-206. PubMed ID: 22076708
[TBL] [Abstract][Full Text] [Related]
33. Combined mutational analysis of RAS, BRAF, PIK3CA, and TP53 genes in Taiwanese patients with oral squamous cell carcinoma.
Chang YS; Hsu HT; Ko YC; Yeh KT; Chang SJ; Lin CY; Chang JG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jul; 118(1):110-116.e1. PubMed ID: 24908601
[TBL] [Abstract][Full Text] [Related]
34. [Detection of TP53-mutations in brush biopsies from oral leukoplakias].
Scheifele C; Schlechte H; Bethke G; Reichart PA
Mund Kiefer Gesichtschir; 2002 Nov; 6(6):410-4. PubMed ID: 12447653
[TBL] [Abstract][Full Text] [Related]
35. The status of EGFR CA SSR1 is a potential prognostic factor for patients with oral squamous cell carcinoma.
Lin YL; Wang WY; Lin JC; Wong YK; Chien YC
Oral Oncol; 2011 Jun; 47(6):482-6. PubMed ID: 21530363
[TBL] [Abstract][Full Text] [Related]
36. Single nucleotide polymorphism in esophageal cancer related gene 1: an analysis in resected oral squamous cell carcinoma patients.
Blessmann M; Pohlenz P; Atac A; Kaifi JT; Eulenburg C; Kalinin V; Merkert P; Smeets R; Heiland M; Blake F; Schmelzle R; Izbicki JR
Int J Oral Maxillofac Surg; 2009 Jul; 38(7):779-84. PubMed ID: 19394797
[TBL] [Abstract][Full Text] [Related]
37. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
38. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
[TBL] [Abstract][Full Text] [Related]
39. Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer.
Ansell A; Farnebo L; Grénman R; Roberg K; Thunell LK
Oral Oncol; 2009 Jan; 45(1):23-9. PubMed ID: 18487077
[TBL] [Abstract][Full Text] [Related]
40. FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects.
Xu W; Li Y; Wang X; Chen B; Wang Y; Liu S; Xu J; Zhao W; Wu J
Eur J Cancer; 2010 Dec; 46(18):3332-8. PubMed ID: 20638838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
